Velosulin BR (Human Buffered Regular Insulin (rDNA origin)) Injection
Company:  Novo Nordisk Pharmaceuticals, Inc.
Application No.:  021-028
Approval Date: 7/19/1999

• Approval Letter(s) (618 KB)

• Final Printed Labeling & Medical Review(s) (2.4 MB)

• Chemistry Review(s) & Statistical Review(s) (1.7 MB)

• Microbiology Review(s) & Clinical Pharmacology Biopharmaceutics Review(s) (2.4 MB)

• Administrative Document(s)/Correspondence
  Part 1 (2.5 MB)
  Part 2 (2.8 MB)

Back to Top     Back to Drugs@FDA

PDF requires the free Adobe Acrobat Reader

Date created: March 30, 2001

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research